Extended Data Fig. 5: Heterogeneity of biomarkers that predict responses to checkpoint blockade.
From: Neoantigen-directed immune escape in lung cancer evolution

a, The TIDE gene-signature score of each tumour region is shown per patient, for patients with more than one region available (n = 39). Using a threshold shown by the dashed line, patients are classified as having high TIDE (light blue), low TIDE (dark blue) or heterogeneous TIDE (orange) scores. b, The IPRES gene-signature score of each tumour region is shown per patient, for patients with more than one region available (n = 39). Using the previously defined threshold13 (shown by the dashed line), patients are classified as having low IPRES (light blue), high IPRES (dark blue) or heterogeneous IPRES (orange) scores. c, The expanded Ayers et al.14 IFN signature is shown for each tumour region per patient, for patients with more than one region available (n = 38). For a–c, the immune classification of the patient is also given. d, The greatest difference in the expanded Ayers et al.14 IFN signature between tumour regions from the same tumour is plotted, according to whether or not the tumour has heterogeneous levels of immune infiltration (n = 38). A two-sided Wilcoxon rank-sum test is used for comparison. e, Tumour mutational burden of each tumour region is shown per patient (n = 93). Using a threshold of ten mutations per megabase (dashed line), patients are classified as having a low (light blue), high (dark blue) or heterogeneous tumour mutational burden (orange). For all box plots, the minimum and maximum are indicated by extreme points of the plot; the median is indicated by a thick horizontal line; and the first and third quartiles are indicated by box edges. f, A summary of the tumour histology, immune classification, tumour mutational burden status, TIDE category and IPRES category is shown for each tumour (n = 93). There is an enrichment for heterogeneously immune infiltrated tumours to have heterogeneous tumour mutational burden status and heterogeneous TIDE scores (Fisher’s exact test). No corrections were made for multiple comparisons.